Browse > Article
http://dx.doi.org/10.3340/jkns.2015.57.6.390

Epidemiology of Moyamoya Disease in Korea: Based on National Health Insurance Service Data  

Kim, Tackeun (Department of Neurosurgery, Seoul National University Bundang Hospital)
Lee, Heeyoung (Department of Neurosurgery, Seoul National University College of Medicine)
Bang, Jae Seung (Department of Neurosurgery, Seoul National University Bundang Hospital)
Kwon, O-Ki (Department of Neurosurgery, Seoul National University Bundang Hospital)
Hwang, Gyojun (Department of Neurosurgery, Seoul National University Bundang Hospital)
Oh, Chang Wan (Department of Neurosurgery, Seoul National University Bundang Hospital)
Publication Information
Journal of Korean Neurosurgical Society / v.57, no.6, 2015 , pp. 390-395 More about this Journal
Abstract
There have been a few studies reporting the epidemiology of moyamoya disease in Korea. Previous studies revealed relatively high prevalence and incidence of moyamoya disease in Korea and Japan. This study was designed to provide the latest epidemiologic information of moyamoya disease in Korea. We analyzed a database comprising of 50 million people covered in Korea by the National Health Insurance Service to calculate the prevalence. The incidence was estimated by eliminating the duplicated records of previous 3 years. We summarized the prevalence and incidence according to age, sex, and local distribution. In addition, the chronological changes were demonstrated with direct standardization using the 2010 population structure information. The standardized prevalence was 6.5 per 100000 persons in 2005, which was increased to 18.1 in 2013. In the same period, standardized incidence was increased from 2.7 to 4.3 per 100000 persons. The prevalence for men was 4.9 and 8.3 for women in 2005. In 2013, the prevalence had increased for men and women to 13.8 and 25.3, respectively. The incidence for men and women was 2.2 and 3.2, respectively, in 2005. It had increased to 3.5 and 5.7, respectively. The mean age of patients was 33.5 in 2005 and increased to 42.5 in 2013. The peak prevalent age group had shifted slightly to the older age groups, with chronologically consistent female predominance. The prevalence was highest in Jeollabuk province and lowest in Ulsan city.
Keywords
Epidemiology; Korea; Moyamoya disease;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kuroda S, Houkin K. Moyamoya disease : current concepts and future perspectives. Lancet Neurol 7 : 1056-1066, 2008   DOI
2 Hung CC, Tu YK, Su CF, Lin LS, Shih CJ : Epidemiological study of moyamoya disease in Taiwan. Clin Neurol Neurosurg 99 Suppl 2 : S23-S25, 1997
3 Ahn IM, Park DH, Hann HJ, Kim KH, Kim HJ, Ahn HS : Incidence, prevalence, and survival of moyamoya disease in Korea : a nationwide, population-based study. Stroke 45 : 1090-1095, 2014   DOI
4 Baba T, Houkin K, Kuroda S : Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry 79 : 900-904, 2008   DOI
5 Chen PC, Yang SH, Chien KL, Tsai IJ, Kuo MF : Epidemiology of moyamoya disease in Taiwan : a nationwide population-based study. Stroke 45 : 1258-1263, 2014   DOI
6 Choi KS : Moyamoya disease in Korea. A cooperative study in Suzuki J (ed) : Advances in Surgery for Cerebral Stroke. Tokyo : Springer-Verlag, 1988, pp107-109
7 Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, Hashimoto S, et al. : Prevalence and clinicoepidemiological features of moyamoya disease in Japan : findings from a nationwide epidemiological survey. Stroke 39 : 42-47, 2008   DOI
8 Ikezaki K, Han DH, Kawano T, Inamura T, Fukui M : Epidemiological survey of moyamoya disease in Korea. Clin Neurol Neurosurg 99 Suppl 2 : S6-S10, 1997
9 Im SH, Cho CB, Joo WI, Chough CK, Park HK, Lee KJ, et al. : Prevalence and epidemiological features of moyamoya disease in Korea. J Cerebrovasc Endovasc Neurosurg 14 : 75-78, 2012   DOI
10 Kleinloog R, Regli L, Rinkel GJ, Klijn CJ : Regional differences in incidence and patient characteristics of moyamoya disease : a systematic review. J Neurol Neurosurg Psychiatry 83 : 531-536, 2012   DOI
11 Liu W, Hitomi T, Kobayashi H, Harada KH, Koizumi A : Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations. Neurol Med Chir (Tokyo) 52 : 299-303, 2012   DOI
12 Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, et al. : Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One 6 : e22542, 2011   DOI
13 Miao W, Zhao PL, Zhang YS, Liu HY, Chang Y, Ma J, et al. : Epidemiological and clinical features of Moyamoya disease in Nanjing, China. Clin Neurol Neurosurg 112 : 199-203, 2010   DOI
14 Miyamoto S, Yoshimoto T, Hashimoto N, Okada Y, Tsuji I, Tominaga T, et al. : Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease : results of the Japan Adult Moyamoya Trial. Stroke 45 : 1415-1421, 2014   DOI
15 Suzuki J, Kodama N : Moyamoya disease--a review. Stroke 14 : 104-109, 1983   DOI
16 Nam DH, Oh CW, Wang KC, Paek SH, Hwang YS, Kim IO, et al. : Moyamoya disease : the differences between age groups in clinical presentation and hemodynamic characteristics. J Korean Neurosurg Soc 26 : 1357-1362, 1997
17 Natori Y, Ikezaki K, Matsushima T, Fukui M : 'Angiographic moyamoya' its definition, classification, and therapy. Clin Neurol Neurosurg 99 Suppl 2 : S168-S172, 1997
18 Saeki N, Nakazaki S, Kubota M, Yamaura A, Hoshi S, Sunada S, et al. : Hemorrhagic type moyamoya disease. Clin Neurol Neurosurg 99 Suppl 2 : S196-S201, 1997
19 Suzuki J, Takaku A : Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20 : 288-299, 1969   DOI
20 Uchino K, Johnston SC, Becker KJ, Tirschwell DL : Moyamoya disease in Washington State and California. Neurology 65 : 956-958, 2005   DOI
21 Wakai K, Tamakoshi A, Ikezaki K, Fukui M, Kawamura T, Aoki R, et al. : Epidemiological features of moyamoya disease in Japan : findings from a nationwide survey. Clin Neurol Neurosurg 99 Suppl 2 : S1-S5, 1997   DOI
22 Wetjen NM, Garell PC, Stence NV, Loftus CM : Moyamoya disease in the midwestern United States. Neurosurg Focus 5 : e1, 1998
23 Yonekawa Y, Ogata N, Kaku Y, Taub E, Imhof HG : Moyamoya disease in Europe, past and present status. Clin Neurol Neurosurg 99 Suppl 2 : S58-S60, 1997